University of Oxford’s Clinical Trials Office has opened negotiations with Hamad Medical Corporation and Qatar Foundation’s Sidra Medical and Research Center.
“We would like to see Qatar running its own clinical trials in a couple of years,” director Dr Rachel Midgley told Gulf Times yesterday.
The official, on an exploratory visit, is of the view that Qatar can have a centre for running international clinical trials.
“We have a lot of experience in clinical trials,” said Dr Midgley, adding that the purpose of her visit is to examine Qatar’s infrastructure and strengths in this regard.
Dr Midgley met with HMC managing director Dr Hanan al-Kuwari yesterday in the presence of Sidra’s chief research advisor Prof David Kerr, who is to start practising at HMC’s Al Amal Hospital and undertake clinical trials and research.
HMC’s Medical Research Centre chairman Dr Al-Hareth M al-Khater, Al Amal’s executive director Mahmoud al-Raise, chief of staff Dr Hanadi R El Ayoubi, haematology/oncology consultant Dr Mohamed Ussama al-Homsi, and Sidra’s public relations and marketing project director Terry O’Donovan were also present.
http://gulf-times.com/site/topics/article.asp?cu_no=2&item_no=286398&version=1&template_id=36&parent_id=16
Follow us on our social media channels:
@ILQlive
@ILQlive
@ILoveQtr
ILoveQatar
